Get started
Author

Yinghua Ji

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
2022 · Ying Cheng, Liang Han, et al. · JAMA · 540
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
2022 · Zhihao Lu, Junye Wang, et al. · BMJ · 519
PDF
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
2022 · Shun Lu, Xiaorong Dong, et al. · Journal of Clinical Oncology · 342
PDF
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial
2025 · Yuxiang Ma, Yunpeng Yang, et al. · Nature Medicine · 133
Screening of MicroRNA in Patients with Esophageal Cancer at Same Tumor Node Metastasis Stage with Different Prognoses
2013 · Bao-Sheng Zhao, Shang-Guo Liu, et al. · Asian Pacific Journal of Cancer Prevention · 67
Cytokine Release Syndrome After Modified CAR-NK Therapy in an Advanced Non-small Cell Lung Cancer Patient: A Case Report
2022 · Xiaodi Zhang, Yuying Guo, et al. · Cell Transplantation · 61
A plant NLR receptor employs ABA central regulator PP2C-SnRK2 to activate antiviral immunity
2024 · Shen Huang, Chunli Wang, et al. · Nature Communications · 56
PDF
Ab initio investigation of the surface properties of Cu(111) and Li diffusion in Cu thin film
2005 · Zhihua Xiong, Siqi Shi, et al. · Physics Letters A · 51
Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells
2015 · Ji Yinghua, Di Wenyu, et al. · Clinical Laboratory · 45
Improving entanglement of even entangled coherent states by a coherent superposition of photon subtraction and addition
2015 · Jiani Wu, Shiyou Liu, et al. · Journal of the Optical Society of America B · 44
PDF
A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial
2025 · Chang Liu, Dan Liu, et al. · Nature Medicine · 43
PDF
Synovial sarcoma: Magnetic resonance and computed tomography imaging features and differential diagnostic considerations
2014 · CHANGHUA LIANG, HUAJIE MAO, et al. · Oncology Letters · 42
PDF
IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling.
2014 · Yinghua Ji, Xiaoyu Yang, et al. · PubMed · 41
Ab initiostudies on the stability and electronic structure of LiCoO2 (003) surfaces
2005 · Liyun Hu, Zhihua Xiong, et al. · Physical Review B · 38
Tomato Yellow Leaf Curl Virus V2 Protein Plays a Critical Role in the Nuclear Export of V1 Protein and Viral Systemic Infection
2020 · Wenhao Zhao, Yinghua Ji, et al. · Frontiers in Microbiology · 37
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study
2022 · Yuankai Shi, Baolan Li, et al. · Journal of Thoracic Oncology · 36
PDF
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR ‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS)
2024 · Shun Lu, Xiaorong Dong, et al. · 癌症：英文版 · 34
PDF
Serplulimab, a novel anti-PD-1 antibody, plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small-cell lung cancer: An international randomized phase 3 study.
2022 · Ying Cheng, Liang Han, et al. · Journal of Clinical Oncology · 34
First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial
2025 · Ying Cheng, Shuang Zhang, et al. · 癌症：英文版 · 31
PDF
Autophagy inhibition enhances colorectal cancer apoptosis induced by dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235
2016 · XIAOYU YANG, BINGXUAN NIU, et al. · Oncology Letters · 31
PDF
Randomized phase III trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm).
2021 · Shun Lu, Xiaorong Dong, et al. · Journal of Clinical Oncology · 30
Hypermethylation Of ADHFE1 Promotes The Proliferation Of Colorectal Cancer Cell Via Modulating Cell Cycle Progression
2019 · Yu-Han Hu, Shuai Ma, et al. · OncoTargets and Therapy · 28
PDF
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
2021 · Yuankai Shi, Kaijian Lei, et al. · 癌症：英文版 · 27
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study
2024 · Xiangrui Meng, Junsheng Wang, et al. · European Journal of Cancer · 26
Optimal control-based states transfer for non-Markovian quantum system
2016 · Ji Ying-Hua, Hu Ju-ju, et al. · Physica E Low-dimensional Systems and Nanostructures · 25
Works count: 160
Citation count: 2,981
H-index: 25
I10-index: 49
Year
Topic
Type